Two cases of serious rhabdomyolysis during linezolid treatment

Linezolid is an oxazolidinone antibiotic with activity against gram-positive organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA). To the best of our knowledge, there are only two case reports on rhabdomyolysis in patients treated with linezolid. Here, we describe two cases of...

Descripción completa

Detalles Bibliográficos
Autores principales: Lechner, Arno M., Past, Eva, Porsche, Ulla, Kern, Jan M., Hoppe, Uta, Pretsch, Ingrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5529475/
https://www.ncbi.nlm.nih.gov/pubmed/28083787
http://dx.doi.org/10.1007/s15010-016-0978-8
Descripción
Sumario:Linezolid is an oxazolidinone antibiotic with activity against gram-positive organisms, particularly methicillin-resistant Staphylococcus aureus (MRSA). To the best of our knowledge, there are only two case reports on rhabdomyolysis in patients treated with linezolid. Here, we describe two cases of serious rhabdomyolysis: one in a patient with septic community-acquired (CA)-MRSA pneumonia and a second case in a patient with suspected catheter-related blood stream infection.

Ejemplares similares